Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Gastric Cancer × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 42 Sarcoma 20 Neoplasms 18 Neoplasm Metastasis 13 Ovarian Neoplasms 10 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Melanoma 5 Thyroid Neoplasms 4 Hemangiosarcoma 4 Fallopian Tube Neoplasms 4 Urinary Bladder Neoplasms 3 Solid Tumors 3 Recurrence 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Liposarcoma 3 Leiomyosarcoma 3 Kidney Neoplasms 3 Colorectal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Ovarian Epithelial 3 Sarcoma, Synovial 2 Refractory Solid Tumors 2 Neuroendocrine Tumors 2 Gliosarcoma 2 Glioblastoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2

Interventions

Oxaliplatin 5 Capecitabine 5 Cisplatin 4 Paclitaxel 3 Fluorouracil 3 camrelizumab 2 apatinib 2 S 1 (combination) 2 Leucovorin 2 Docetaxel 2 titanium silicide 1 rucaparib 1 relatlimab 1 pazopanib 1 linrodostat 1 ezogabine 1 endostar protein 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Nivolumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Epirubicin 1 Electroporation 1 Drug Therapy, Combination 1 Drug Therapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01503372 2019-02-12

PaFLO

Charite University, Berlin, Germany

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡